NeuroBo Pharmaceuticals News

NeuroBo Pharmaceuticals | 8-K: Neurobo Pharmaceuticals Completes Last Patient Last Visit in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH

Nov 4 21:34

NeuroBo Pharmaceuticals | 8-K: Posted an Updated Corporate Presentation to Its Website

Oct 7 19:03

NeuroBo Pharmaceuticals | 8-K: NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

Sep 30 20:08

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner DONG-A ST CO., LTD

Sep 21 04:23

NeuroBo Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dong-A ST Co., Ltd.(54.95%)

Sep 21 04:18

NeuroBo Pharmaceuticals | 8-K: Company Held a Virtual Special Meeting of Stockholders

Sep 20 04:15

NeuroBo Pharmaceuticals | DEF 14A: Definitive information statements

Aug 22 04:06

NeuroBo Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 15 05:11

NeuroBo Pharmaceuticals | 8-K: NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 14 20:05

NeuroBo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kim Hyung Heon

Aug 14 04:03

NeuroBo Pharmaceuticals | 8-K: NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

Aug 13 20:32

NeuroBo Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 7 20:01

NeuroBo Pharmaceuticals | 8-K: NeuroBo Pharmaceuticals Announces Joint Research Agreement

Aug 6 20:33

NeuroBo Pharmaceuticals | 8-K: Neurobo Pharmaceuticals Announces Exclusive License Agreement with Mthera Pharma for Nb-01

Jul 30 20:35

NeuroBo Pharmaceuticals | EFFECT: Others

Jul 25 18:05

NeuroBo Pharmaceuticals | 424B3: Prospectus

Jul 25 05:15

NeuroBo Pharmaceuticals | UPLOAD: Others

Jul 23 01:24

NeuroBo Pharmaceuticals | CORRESP: CORRESP

Jul 23 01:24

NeuroBo Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933

Jul 18 20:26

NeuroBo Pharmaceuticals | 8-K: Neurobo Pharmaceuticals, Inc. Posted an Updated Corporate Presentation

Jul 16 20:32